Angitia Biopharmaceuticals

Angitia Biopharmaceuticals is a clinical-stage biopharmaceutical company founded in 2018, headquartered at 3027 Townsgate Road, Westlake Village, California, with research and development operations in Guangzhou, China. It discovers and develops biologic therapeutics for serious musculoskeletal diseases, including osteoporosis, osteogenesis imperfecta, bone metastasis, osteoarthritis and muscle disorders. Its clinical pipeline is led by AGA2118 and AGA2115, bispecific antibodies targeting sclerostin and DKK1, alongside AGA111 in lumbar interbody fusion. The company closed a $120 million Series C financing in December 2024 led by Bain Capital Life Sciences. Angitia is a drug developer, not a software vendor: it publishes no API, developer portal, SDK, machine-readable specification, or technology platform of any kind. Its only machine-readable public surface is an XML sitemap and a robots.txt carrying Cloudflare-managed Content-Signal directives that reserve AI training rights.

Angitia Biopharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Biopharmaceuticals, Pharmaceuticals, and Life Sciences.

Angitia Biopharmaceuticals’ developer surface includes product news, support, and 6 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.2/100 minimal ▬ flat Agent 3/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyBiotechnologyBiopharmaceuticalsPharmaceuticalsLife SciencesDrug DevelopmentClinical TrialsHealthcareMusculoskeletalTherapeutics

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 11.2/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.7 / 17

Commercial Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 3/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 3 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/angitia-biopharmaceuticals: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 3

The organization behind the API

Website

Website

About

About

News

News

Other 1

Properties that don't map to a standard resource type

ContentSignal

ContentSignal

Source (apis.yml)

aid: angitia-biopharmaceuticals
name: Angitia Biopharmaceuticals
description: 'Angitia Biopharmaceuticals is a clinical-stage biopharmaceutical company founded in 2018, headquartered at 3027
  Townsgate Road, Westlake Village, California, with research and development operations in Guangzhou, China. It discovers
  and develops biologic therapeutics for serious musculoskeletal diseases, including osteoporosis, osteogenesis imperfecta,
  bone metastasis, osteoarthritis and muscle disorders. Its clinical pipeline is led by AGA2118 and AGA2115, bispecific antibodies
  targeting sclerostin and DKK1, alongside AGA111 in lumbar interbody fusion. The company closed a $120 million Series C financing
  in December 2024 led by Bain Capital Life Sciences. Angitia is a drug developer, not a software vendor: it publishes no
  API, developer portal, SDK, machine-readable specification, or technology platform of any kind. Its only machine-readable
  public surface is an XML sitemap and a robots.txt carrying Cloudflare-managed Content-Signal directives that reserve AI
  training rights.'
image: https://www.angitiabio.com/home/img/logo.png
url: https://raw.githubusercontent.com/api-evangelist/angitia-biopharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Biopharmaceuticals
- Pharmaceuticals
- Life Sciences
- Drug Development
- Clinical Trials
- Healthcare
- Musculoskeletal
- Therapeutics
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Angitia is a clinical-stage drug developer whose product is a bispecific antibody, not software; angitiabio.com
    is a seven-page corporate brochure site and every API discovery path on it returns 404, with api., developer., docs. and
    portal.angitiabio.com all NXDOMAIN.
  evidence:
  - url: https://www.angitiabio.com/openapi.json
    status: 404
  - url: https://www.angitiabio.com/.well-known/agent-card.json
    status: 404
  - url: https://www.angitiabio.com/developers
    status: 404
  - url: https://www.angitiabio.com/sitemap.xml
    status: 200
  checked: '2026-08-06'
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
apis: []
common:
- type: Website
  url: https://www.angitiabio.com/
- type: About
  url: https://www.angitiabio.com/aboutus
- type: News
  url: https://www.angitiabio.com/news
- type: Support
  url: https://www.angitiabio.com/contact
- type: TermsOfService
  url: https://www.angitiabio.com/terms
- type: PrivacyPolicy
  url: https://www.angitiabio.com/privacypolicy
- type: ContentSignal
  url: well-known/angitia-biopharmaceuticals-robots.txt
- type: DomainSecurity
  url: security/angitia-biopharmaceuticals-domain-security.yml